Log in

Sanofi News Headlines (NYSE:SNY)

$46.03
-0.05 (-0.11 %)
(As of 12/6/2019 04:00 PM ET)
Today's Range
$45.97
Now: $46.03
$46.33
50-Day Range
$45.03
MA: $46.17
$47.20
52-Week Range
$40.00
Now: $46.03
$47.47
Volume1.10 million shs
Average Volume1.33 million shs
Market Capitalization$115.27 billion
P/E Ratio14.71
Dividend Yield2.52%
Beta0.67

Headlines

Sanofi (NYSE SNY) News Headlines

Source:
DateHeadline
Not Much Chemistry Between Sanofi (SNY) and Hedge Funds - Yahoo FinanceNot Much Chemistry Between Sanofi (SNY) and Hedge Funds - Yahoo Finance
finance.yahoo.com - December 6 at 1:10 PM
Not Much Chemistry Between Sanofi (SNY) and Hedge FundsNot Much Chemistry Between Sanofi (SNY) and Hedge Funds
finance.yahoo.com - December 6 at 1:10 PM
Barclays Downgrades Sanofi (NYSE:SNY) to UnderweightBarclays Downgrades Sanofi (NYSE:SNY) to Underweight
www.americanbankingnews.com - December 6 at 12:45 PM
Sanofi Sees Unusually High Options Volume (NYSE:SNY)Sanofi Sees Unusually High Options Volume (NYSE:SNY)
www.americanbankingnews.com - December 5 at 6:38 AM
Najarian Brothers Highlight Unusual Option Activity In Sanofi, JetBlue And More - BenzingaNajarian Brothers Highlight Unusual Option Activity In Sanofi, JetBlue And More - Benzinga
www.benzinga.com - December 4 at 6:11 PM
Is Sanofis Stock a Buy? - Motley FoolIs Sanofi's Stock a Buy? - Motley Fool
www.fool.com - December 4 at 6:11 PM
Sanofi agrees to sell Seprafilm to Baxter for $350 mln - NasdaqSanofi agrees to sell Seprafilm to Baxter for $350 mln - Nasdaq
www.nasdaq.com - December 2 at 12:12 PM
Why Lexicon Pharma Shares Are Moving LowerWhy Lexicon Pharma Shares Are Moving Lower
feeds.benzinga.com - December 2 at 11:43 AM
Jefferies Financial Group Equities Analysts Cut Earnings Estimates for Sanofi SA (NYSE:SNY)Jefferies Financial Group Equities Analysts Cut Earnings Estimates for Sanofi SA (NYSE:SNY)
www.americanbankingnews.com - December 2 at 1:17 AM
Jefferies Financial Group Comments on Sanofi SAs FY2019 Earnings (NYSE:SNY)Jefferies Financial Group Comments on Sanofi SA's FY2019 Earnings (NYSE:SNY)
www.americanbankingnews.com - November 28 at 6:45 AM
Why Sanofi Cant Match Novo Nordisk - Seeking AlphaWhy Sanofi Can't Match Novo Nordisk - Seeking Alpha
seekingalpha.com - November 27 at 10:32 PM
First Week of January 2020 Options Trading For Sanofi (SNY) - NasdaqFirst Week of January 2020 Options Trading For Sanofi (SNY) - Nasdaq
www.nasdaq.com - November 26 at 11:57 AM
Epidemic of Fear: How the Trouble-Ridden Debut of a Breakthrough Vaccine Sparked a Panic - FortuneEpidemic of Fear: How the Trouble-Ridden Debut of a Breakthrough Vaccine Sparked a Panic - Fortune
fortune.com - November 26 at 6:56 AM
Novartis (NVS) to Acquire The Medicines Company for $9.7BNovartis (NVS) to Acquire The Medicines Company for $9.7B
finance.yahoo.com - November 25 at 1:08 PM
Sanofi strategy head to exit - ReutersSanofi strategy head to exit - Reuters
seekingalpha.com - November 22 at 6:54 PM
Exclusive: Sanofis strategy boss to leave as CEO readies revamp - ReutersExclusive: Sanofi's strategy boss to leave as CEO readies revamp - Reuters
www.reuters.com - November 22 at 8:53 AM
Sanofi SA (NYSE:SNY) Given Consensus Rating of "Buy" by AnalystsSanofi SA (NYSE:SNY) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - November 22 at 3:43 AM
AI Sirona (Luxembourg) Acquisition S.a.r.l. -- Moodys affirms Zentivas B3 CFR; outlook stableAI Sirona (Luxembourg) Acquisition S.a.r.l. -- Moody's affirms Zentiva's B3 CFR; outlook stable
finance.yahoo.com - November 21 at 3:01 PM
‘There’s Never Been a Better Time’ to Be a CEO, Says Sanofi’s Chief Executive - Fortune‘There’s Never Been a Better Time’ to Be a CEO, Says Sanofi’s Chief Executive - Fortune
fortune.com - November 19 at 5:26 PM
A $5 Billion Cholesterol Bet May Be an OverreachA $5 Billion Cholesterol Bet May Be an Overreach
finance.yahoo.com - November 19 at 12:25 PM
The Zacks Analyst Blog Highlights: Chevron, HSBC, Sanofi, Sony and Moody'sThe Zacks Analyst Blog Highlights: Chevron, HSBC, Sanofi, Sony and Moody's
finance.yahoo.com - November 18 at 10:26 AM
Regeneron Rebounds Again: A Progress ReportRegeneron Rebounds Again: A Progress Report
seekingalpha.com - November 18 at 5:23 AM
Amarin (AMRN) Gets FDA Panel Nod for Vascepa Label ExpansionAmarin (AMRN) Gets FDA Panel Nod for Vascepa Label Expansion
finance.yahoo.com - November 15 at 12:38 PM
Sanofi (NYSE:SNY) Stock Rating Reaffirmed by ArgusSanofi (NYSE:SNY) Stock Rating Reaffirmed by Argus
www.americanbankingnews.com - November 13 at 9:52 AM
Emergent (EBS) Beat Earnings in Q3, Vaccines Drive SalesEmergent (EBS) Beat Earnings in Q3, Vaccines Drive Sales
finance.yahoo.com - November 7 at 12:37 PM
Sanofi : FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older - GlobeNewswireSanofi : FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older - GlobeNewswire
www.globenewswire.com - November 4 at 5:38 PM
Sanofi settles 4-year legal battle over Genzyme drug for $315M - Boston Business JournalSanofi settles 4-year legal battle over Genzyme drug for $315M - Boston Business Journal
www.bizjournals.com - November 4 at 5:38 PM
FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and olderFDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older
finance.yahoo.com - November 4 at 5:38 PM
Sanofi: Positive Toujeo Study Results In 6 To 17 Years With Type 1 Diabetes - NasdaqSanofi: Positive Toujeo Study Results In 6 To 17 Years With Type 1 Diabetes - Nasdaq
www.nasdaq.com - November 4 at 7:37 AM
Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetesPositive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes
finance.yahoo.com - November 4 at 7:37 AM
Sanofi (SNY) Reports Q3 EPS of EUR1.92 - StreetInsider.comSanofi (SNY) Reports Q3 EPS of EUR1.92 - StreetInsider.com
www.streetinsider.com - November 2 at 12:18 AM
Sanofi Q3 well on track - PRNewswireSanofi Q3 well on track - PRNewswire
www.prnewswire.com - November 1 at 9:17 AM
Sanofi (SNY) Q3 2019 Earnings Call Transcript - Motley FoolSanofi (SNY) Q3 2019 Earnings Call Transcript - Motley Fool
www.fool.com - November 1 at 9:17 AM
Sanofi: 3Q Earnings SnapshotSanofi: 3Q Earnings Snapshot
finance.yahoo.com - October 31 at 11:02 PM
Sanofi ADR (SNY) Earnings Report DateSanofi ADR (SNY) Earnings Report Date
www.nasdaq.com - October 31 at 11:02 PM
Sanofi confident for 2019 despite third-quarter sales slip - Yahoo FinanceSanofi confident for 2019 despite third-quarter sales slip - Yahoo Finance
finance.yahoo.com - October 31 at 1:00 PM
Sanofi confident for 2019 despite Q3 sales slip - NasdaqSanofi confident for 2019 despite Q3 sales slip - Nasdaq
www.nasdaq.com - October 31 at 1:00 PM
Sanofi (SNY) Q3 Earnings Beat, Vaccines/CHC Units Hurt Sales - NasdaqSanofi (SNY) Q3 Earnings Beat, Vaccines/CHC Units Hurt Sales - Nasdaq
www.nasdaq.com - October 31 at 1:00 PM
Sanofi Profit Beats Estimates With New CEO Hudson at Helm - BloombergSanofi Profit Beats Estimates With New CEO Hudson at Helm - Bloomberg
www.bloomberg.com - October 31 at 1:00 PM
Sanofi Profit Beats Estimates With New CEO Hudson at Helm - Yahoo FinanceSanofi Profit Beats Estimates With New CEO Hudson at Helm - Yahoo Finance
finance.yahoo.com - October 31 at 8:00 AM
Sanofi confident for 2019 despite third-quarter sales slip - ReutersSanofi confident for 2019 despite third-quarter sales slip - Reuters
www.reuters.com - October 31 at 8:00 AM
Sanofi Q3 well on track - StreetInsider.comSanofi Q3 well on track - StreetInsider.com
www.streetinsider.com - October 31 at 8:00 AM
Sanofi announces settlement agreement related to Contingent Value Rights (CVRs) Litigation - GlobeNewswireSanofi announces settlement agreement related to Contingent Value Rights (CVRs) Litigation - GlobeNewswire
www.globenewswire.com - October 31 at 8:00 AM
Sanofi announces settlement agreement related to Contingent Value Rights (CVRs) Litigation - Yahoo FinanceSanofi announces settlement agreement related to Contingent Value Rights (CVRs) Litigation - Yahoo Finance
finance.yahoo.com - October 31 at 12:05 AM
Regeneron, Sanofi: European Commission Approves New Indication For Dupixent - NasdaqRegeneron, Sanofi: European Commission Approves New Indication For Dupixent - Nasdaq
www.nasdaq.com - October 29 at 1:17 PM
The Sanofi (EPA:SAN) Share Price Is Up 18% And Shareholders Are Holding On - Yahoo FinanceThe Sanofi (EPA:SAN) Share Price Is Up 18% And Shareholders Are Holding On - Yahoo Finance
finance.yahoo.com - October 29 at 8:17 AM
Sanofi (SNY) to Report Q3 Earnings: Whats in the Cards? - Yahoo FinanceSanofi (SNY) to Report Q3 Earnings: What's in the Cards? - Yahoo Finance
finance.yahoo.com - October 28 at 6:31 PM
Hancock launches new life insurance product for diabetesHancock launches new life insurance product for diabetes
finance.yahoo.com - October 28 at 6:31 PM
Sanofi (SNY) to Report Q3 Earnings: Whats in the Cards?Sanofi (SNY) to Report Q3 Earnings: What's in the Cards?
www.nasdaq.com - October 28 at 1:31 PM
Sanofi (SNY) to Report Q3 Earnings: What's in the Cards?Sanofi (SNY) to Report Q3 Earnings: What's in the Cards?
finance.yahoo.com - October 28 at 1:30 PM
This page was last updated on 12/7/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel